Study of IV tocilizumab for GCA that led to FDA approval of intravenous TCZ this year (2/2022) -one of Dr. C Langford's pick for #YearinReview
@rheumnow #ACR22 https://t.co/luxDDluddM
Links:
Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia R…
https://jamanetwork.com/journals/jama/fullarticle/2796378
Nov-12-2022
